Treatment Options for Low Free Testosterone
Testosterone replacement therapy (TRT) is the primary treatment for confirmed low free testosterone, with transdermal preparations (gels, patches) generally preferred as first-line options due to their steady-state pharmacokinetics. 1, 2
Diagnostic Confirmation Before Treatment
- Diagnosis requires both consistently low testosterone measurements (<300 ng/dL) on at least two separate morning tests AND the presence of symptoms/signs 1
- Free testosterone measurement is essential when evaluating patients with obesity or suspected binding protein abnormalities 1, 2
- Clinical symptoms warranting evaluation include:
Treatment Options
1. Testosterone Replacement Therapy
Transdermal Testosterone Preparations
Intramuscular Injections
Implantable Testosterone Pellets
2. Non-Testosterone Options
Selective Estrogen Receptor Modulators (SERMs)
Human Chorionic Gonadotropin (hCG)
Lifestyle Modifications
Monitoring Therapy
- After initiating treatment, monitor testosterone levels at 2-3 months and after any dose change 1, 2
- For patients receiving testosterone injections, measure levels midway between injections 1
- Once stable levels are confirmed, monitoring every 6-12 months is typically sufficient 1
- Target normal free testosterone levels rather than just total testosterone 1, 2
Special Considerations
- Before initiating treatment, measure luteinizing hormone (LH) levels to determine if hypogonadism is primary or secondary 1, 2
- Consider measuring serum prolactin to rule out hyperprolactinemia 1, 2
- In patients with obesity, low total testosterone may be due to low sex hormone-binding globulin (SHBG) 3, 1
- Testosterone therapy should be avoided in patients with prostate or breast cancer, erythrocytosis, untreated obstructive sleep apnea, or severe heart failure 7
Common Pitfalls to Avoid
- Relying solely on total testosterone without measuring free testosterone in patients with suspected binding protein abnormalities 1
- Initiating treatment based on a single testosterone measurement rather than confirming with two separate morning tests 1, 8
- Treating patients with testosterone without confirming both low testosterone levels and clinical symptoms 1, 7
- Failing to monitor testosterone levels after initiating therapy 1